Researchers Advocate for Single-Cell Diagnostics for Breast Cancer
Breast Cancer Cells. Credit: National Cancer Institute (Photographer: Dr. Cecil Fox)
Women diagnosed with breast cancer may benefit from having the molecular subtype of different cells within their tumors identified, say University of Cincinnati (UC) researchers in an opinion article published October 24 in the journal Trends in Cancer.
While breast cancer is often treated as a whole, they discuss the growing consensus that cancer cells within a tumor can have multiple origins and respond variably to treatment. The authors advocate for the development of more accurate diagnostic tests to capture molecular irregularities between tumor cells.
"Breast tumors are moving targets because they are really versatile,” says Jun-Lin Guan, PhD, Francis Brunning Professor and Chair of the Department of Cancer at the UC College of Medicine and member of both the Cincinnati Cancer Center and UC Cancer Institute who co-authored the paper with postdoctoral fellow Syn Kok Yeo, PhD. "If you use a treatment that’s targeting one subtype, which kills one type of breast cancer, often the other kind will actually expand. That defeats the purpose of treatment.”
Breast cancer cells differ by the types of molecular markers, some of which are found on their surface, which physicians can test to understand the characteristics of a patient’s cancer and devise the best treatment strategy. For example, women with the HER2+ breast cancer subtype generally have a poorer prognosis than those with the luminal A tumors because of how quickly the cells multiply. Often tumor samples are taken and screened for the most common markers present, but Guan and Yeo’s analysis of human and animal studies raise the possibility that overlapping subtypes are being missed.
They advocate for diagnostic testing to be combined with single-cell technologies, in which individual cells, rather than a collection, are screened for molecular markers. However, as they currently exist, single-cell approaches are expensive and require specialized expertise and so would not be realistic for regular patient screenings.
"What we’re talking about is still not widely used in practice—there’s a gap between basic cancer research and the clinics that do the diagnoses,” Guan says. "However, single cell technologies are advancing very quickly, so it’s possible that we can see them being used in the near future.”
The researchers say that the co-existence of distinct breast cancer subtypes within tumors happen because a fraction of breast cancer cells retain many stem cell-like qualities and thus reserve the capability to easily change. This has been observed in human cancer cells and in rodent studies but has yet to be confirmed in patients. Single-cell analysis could assess whether this problem is common or rare in humans.
This work was supported by the National Institutes of Health.
This article has been republished from materials provided by the University of Cincinnati. Note: material may have been edited for length and content. For further information, please contact the cited source.
Yeo, S. K., & Guan, J. (2017). Breast Cancer: Multiple Subtypes within a Tumor? Trends in Cancer. doi:10.1016/j.trecan.2017.09.001
Improved Capture of Free-Floating Cancer Cells, Cast-Off from TumorsNews
Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center and University of Wisconsin-Madison have demonstrated improved methods of capturing free-floating cancer cells that are cast-off from tumors, and circulating in the blood.READ MORE
Stress Cancer Cells to Death: Turning Off Autophagy Helps ChemotherapyNews
A University of Colorado Cancer Center study published today pinpoints a molecule that links autophagy and apoptosis, namely a transcription factor called FOXO3a. While researchers have known of the relationship between autophagy and apoptosis, what creates this link hasn’t been clear – in other words, we have known that turning off autophagy can help drugs push cancer cells into apoptosis, but we haven’t known how.READ MORE
Comments | 0 ADD COMMENT
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018